156 related articles for article (PubMed ID: 8989249)
1. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I.
Husebye ES; Gebre-Medhin G; Tuomi T; Perheentupa J; Landin-Olsson M; Gustafsson J; Rorsman F; Kämpe O
J Clin Endocrinol Metab; 1997 Jan; 82(1):147-50. PubMed ID: 8989249
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease.
Söderbergh A; Rorsman F; Halonen M; Ekwall O; Björses P; Kämpe O; Husebye ES
J Clin Endocrinol Metab; 2000 Jan; 85(1):460-3. PubMed ID: 10634424
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of human aromatic L-amino acid decarboxylase.
Bratland E; Wolff AS; Haavik J; Kämpe O; Sköldberg F; Perheentupa J; Bredholt G; Knappskog PM; Husebye ES
Biochem Biophys Res Commun; 2007 Feb; 353(3):692-8. PubMed ID: 17194446
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I.
Gebre-Medhin G; Husebye ES; Gustafsson J; Winqvist O; Goksøyr A; Rorsman F; Kämpe O
FEBS Lett; 1997 Aug; 412(3):439-45. PubMed ID: 9276443
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase.
Dal Pra C; Chen S; Betterle C; Zanchetta R; McGrath V; Furmaniak J; Rees Smith B
Eur J Endocrinol; 2004 Mar; 150(3):313-21. PubMed ID: 15012616
[TBL] [Abstract][Full Text] [Related]
6. Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease.
Sköldberg F; Rorsman F; Perheentupa J; Landin-Olsson M; Husebye ES; Gustafsson J; Kämpe O
J Clin Endocrinol Metab; 2004 Apr; 89(4):1636-40. PubMed ID: 15070923
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies.
Husebye ES; Boe AS; Rorsman F; Kämpe O; Aakvaag A; Rygh T; Flatmark T; Haavik J
Clin Exp Immunol; 2000 Jun; 120(3):420-3. PubMed ID: 10844518
[TBL] [Abstract][Full Text] [Related]
8. Mapping of human autoantibody epitopes on aromatic L-amino acid decarboxylase.
Candeloro P; Voltattorni CB; Perniola R; Bertoldi M; Betterle C; Mannelli M; Giordano R; De Bellis A; Tiberti C; Laureti S; Santeusanio F; Falorni A
J Clin Endocrinol Metab; 2007 Mar; 92(3):1096-105. PubMed ID: 17200166
[TBL] [Abstract][Full Text] [Related]
9. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
Björk E; Velloso LA; Kämpe O; Karlsson FA
Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
[TBL] [Abstract][Full Text] [Related]
10. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II.
Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA
Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849
[TBL] [Abstract][Full Text] [Related]
11. Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen.
Rorsman F; Husebye ES; Winqvist O; Björk E; Karlsson FA; Kämpe O
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8626-9. PubMed ID: 7567987
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems.
Fetissov SO; Bensing S; Mulder J; Le Maitre E; Hulting AL; Harkany T; Ekwall O; Sköldberg F; Husebye ES; Perheentupa J; Rorsman F; Kämpe O; Hökfelt T
J Comp Neurol; 2009 Mar; 513(1):1-20. PubMed ID: 19107747
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
Myhre AG; Halonen M; Eskelin P; Ekwall O; Hedstrand H; Rorsman F; Kämpe O; Husebye ES
Clin Endocrinol (Oxf); 2001 Feb; 54(2):211-7. PubMed ID: 11207636
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.
Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA
Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity.
Bratland E; Magitta NF; Bøe Wolff AS; Ekern T; Knappskog PM; Kämpe O; Haavik J; Husebye ES
Immunobiology; 2013 Jun; 218(6):899-909. PubMed ID: 23182718
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal immunity against tryptophan hydroxylase-1, aromatic L-amino-acid decarboxylase, AIE-75, villin and Paneth cells in APECED.
Kluger N; Jokinen M; Lintulahti A; Krohn K; Ranki A
Clin Immunol; 2015 Jun; 158(2):212-20. PubMed ID: 25805658
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome.
Söderbergh A; Gustafsson J; Ekwall O; Hallgren A; Nilsson T; Kämpe O; Rorsman F; Annerén G
Acta Paediatr; 2006 Dec; 95(12):1657-60. PubMed ID: 17129978
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
19. Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I.
Ekwall O; Hedstrand H; Haavik J; Perheentupa J; Betterle C; Gustafsson J; Husebye E; Rorsman F; Kämpe O
J Clin Endocrinol Metab; 2000 Aug; 85(8):2944-50. PubMed ID: 10946908
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.
Söderbergh A; Myhre AG; Ekwall O; Gebre-Medhin G; Hedstrand H; Landgren E; Miettinen A; Eskelin P; Halonen M; Tuomi T; Gustafsson J; Husebye ES; Perheentupa J; Gylling M; Manns MP; Rorsman F; Kämpe O; Nilsson T
J Clin Endocrinol Metab; 2004 Feb; 89(2):557-62. PubMed ID: 14764761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
